MAR 17, 2015 8:43 AM PDT

Mass Spec and Microscopy Image Fusion

WRITTEN BY: Judy O'Rourke
Vanderbilt University researchers have achieved the first "image fusion" of mass spectrometry and microscopy - a technical tour de force that could, among other things, dramatically improve the diagnosis and treatment of cancer.

Microscopy can yield high-resolution images of tissues, but "it really doesn't give you molecular information," says Richard Caprioli, PhD, senior author of the paper recently published in the journal Nature Methods.
Image of a section of the brain shows the fusion of microscopy (pink area) and mass spectrometry (pixelated colors at bottom) to produce a detailed
Mass spectrometry provides a very precise accounting of the proteins, lipids, and other molecules in a given tissue, but in a spatially coarse or pixelated manner. Combining the best features of both imaging modalities allows scientists to see the molecular make-up of tissues in high resolution.

"That to me is just phenomenal," says Caprioli, the Stanford Moore Professor of Biochemistry and director of the Mass Spectrometry Research Center.

Caprioli says the technique could redefine the surgical "margin," the line between cancer cells and normal cells where the scalpel goes to remove the tumor.

Currently that line is determined by histology - the appearance of cells examined under the microscope. But many cancers recur after surgery. That could be because what appear to be normal cells, when analyzed for their protein content using mass spectrometry, are actually cancer cells in the making.

"The application of image fusion approaches to the analysis of tissue sections by microscopy and mass spectrometry is a significant innovation that should change the way that these techniques are used together," says Douglas Sheeley, ScD, senior scientific officer in the National Institute of General Medical Sciences (NIGMS).

"It is an important step in the process of making mass spectrometry data accessible and truly useful for clinicians," he says.

The image fusion project was led by Raf Van de Plas, PhD, a research assistant professor of biochemistry who also has a faculty position at Delft University of Technology in the Netherlands.

Using a mathematical approach called regression analysis, the researchers mapped each pixel of mass spectrometry data onto the corresponding spot on the microscopy image to produce a new, "predicted" image.

It's similar in concept to the line drawn between experimentally determined points in a standard curve, Caprioli says. There are no "real" points between those that were actually measured, yet the line is predicted by the previous experiments.

In the same way, "we're predicting what the data should look like," he says.

[Source: Vanderbilt University]
About the Author
  • Judy O'Rourke worked as a newspaper reporter before becoming chief editor of Clinical Lab Products magazine. As a freelance writer today, she is interested in finding the story behind the latest developments in medicine and science, and in learning what lies ahead.
You May Also Like
MAY 01, 2020
Cancer
Cancer patients' high mortality from COVID-19
MAY 01, 2020
Cancer patients' high mortality from COVID-19
A study published today in the online edition of Cancer Discovery reports that people with cancer who develop COVID-19 a ...
MAY 14, 2020
Clinical & Molecular DX
New Tech Has Its AI on Brain Tumors
MAY 14, 2020
New Tech Has Its AI on Brain Tumors
  A collaboration across 29 research and healthcare agencies is putting together the world’s largest brain tu ...
MAY 26, 2020
Cancer
Does having a child with cancer increase parents' risk of divorce?
MAY 26, 2020
Does having a child with cancer increase parents' risk of divorce?
A study from Denmark published in the American Cancer Society journal CANCER reports that having a child with cancer doe ...
JUN 01, 2020
Cancer
A New RNA in Fine-Tuned Signal Regulation
JUN 01, 2020
A New RNA in Fine-Tuned Signal Regulation
In a healthy cell, many complex networks work to make sure everything runs as it should. Some of these networks function ...
JUN 22, 2020
Cancer
Black patients are underrepresented in clinical trials
JUN 22, 2020
Black patients are underrepresented in clinical trials
Amidst the swell of racial injustice that the country is bringing to light, new research reports that Black patients are ...
JUL 04, 2020
Cancer
New mechanism that supports the progression and relapse cancer discovered
JUL 04, 2020
New mechanism that supports the progression and relapse cancer discovered
Researchers have found a mechanism of a key protein that supports the progression and relapse of cancer. This discovery ...
Loading Comments...